A history of quality: the milestones

1886

The “Farmacia Internazionale Menarini” opens in Naples

1915

Menarini opens its Florence premises.

1964

Alberto Aleotti is appointed Director General of “Farmaceutica Menarini” and Internationalisation is launched with “Laboratorios Menarini” in Barcelona.

1978

Opening of Menarini Research&Development Division.

Since the 90s

Menarini has expanded its international business rapidly.

1992

Acquisition of Berlin-Chemie which opens up Central-East Europe markets to Menarini.

2003

Opening of Menarini Biotech in Pomezia (Rome).

2009

Lucia e Alberto Giovanni Aleotti leading Menarini.

2011

Acquisition of the Invida Group consolidating Menarini's presence in the Asia Pacific markets.

2013

Acquisition of Silicon Biosystems.

2016

VaxYnethic, a joint venture between Menarini and NewTech Biosynth in vaccines.

CellSearch, pioneer in advanced technologies for cancer diagnostics

2018

Dr Eric Cornut was appointed as new Chairman of the Menarini Group

History

A. Menarini GmbH, the Swiss subsidiary of the Menarini Group, was established in Zurich in 1996. The first products marketed in Switzerland were in the indication fields of pain and inflammation.

These were soon followed by further products in other areas of application, including high blood pressure and shingles, averaging almost one product launch a year!

The number of employees thus increased constantly, and today A. Menarini GmbH employs more than 40 people in the fields of authorisation, medicine, marketing, sales and finance. More than half the workforce is employed in our field service, which supports our endeavour to enter into effective, qualified and reliable cooperation with all our customers.

Our values

 

10 core values have influenced the progress of our group.

READ MORE »

Diagnostics

Advanced technology.

READ MORE »

Quality first


Quality: point of departure and arrival for our drugs.

READ MORE »

Open positions

We are looking for talented people. Discover the opportunities!!

READ MORE »